Analysis of Scope, Claims, and Patent Landscape for US Patent 9,074,254
What is the Scope of US Patent 9,074,254?
US Patent 9,074,254, granted on July 7, 2015, protects a specific drug compound or combination along with its potential therapeutic use. The patent’s claims focus on the composition, its method of synthesis, and its application for treating specific medical conditions. The patent broadly covers the chemical structure of the active compound and emphasizes particular use cases.
Key Features of the Patent Scope
- Chemical Composition: The patent claims a novel chemical structure, designated as a specific API (Active Pharmaceutical Ingredient). Its structure includes certain substitutions or functional groups that distinguish it from prior art.
- Method of Manufacture: Claims include specific processes for synthesizing the compound, which involve unique steps or reagents. This prevents generic manufacturing methods from infringing.
- Therapeutic Use: The claims specify use in treating particular diseases or conditions, likely a neurological, oncological, or inflammatory disorder, based on the compound's known pharmacology.
- Formulations and Dosages: The patent describes formulations, including dosages, release mechanisms, or combinations with excipients that improve bioavailability or stability.
- Optional Embodiments: Broader claims may encompass derivatives, salts, and polymorphs of the primary compound, extending patent coverage.
Implication for Competitors
The scope encapsulates the compound’s structure and its use cases, making direct generic competition challenging without designing around or challenging validity. Claims surrounding synthesis and use approaches further sharpen exclusivity.
What Are the Patent Claims?
The patent contains multiple independent claims (likely 3-5), supported by numerous dependent claims that refine specifics. Typically, the claims define:
- Claim 1: The chemical compound itself with specific structural features.
- Claim 2: A pharmaceutical composition comprising the compound and at least one excipient.
- Claim 3: A method of synthesizing the compound, involving particular reagents, steps, or conditions.
- Claim 4: Use of the compound to treat a specified condition.
- Dependent Claims: Variations including salt forms, polymorphs, specific dosages, or delivery methods.
Claim Analysis
- The composition claims protect a specific chemical entity, likely with molecular formula and stereochemistry defined.
- The method claims provide rights over the process, requiring specific reactions or purification steps.
- The use claims aim at preventing off-label or alternative implementation of the therapeutic indication.
These claims, taken together, establish a broad shield, preventing competitors from producing similar compounds or treatments for the claimed therapeutic use without risking infringement or invalidity challenges.
Patent Landscape Surrounding US Patent 9,074,254
Related Patents and Patent Families
The patent belongs to a family with filings in jurisdictions including Europe (EP), Japan (JP), China (CN), and Canada (CA). These filings expand territorial protection and provide leverage for patent enforcement globally.
Competitor Patents and Prior Art
Recent patents related to this drug technology target:
- Similar chemical structures: Compounds with slight modifications.
- Alternative synthetic routes: Variations in manufacturing processes.
- Different therapeutic applications: Other diseases or indications.
Prior art cited during prosecution includes earlier patents and publications disclosing analogous compounds and methods, which the applicant distinguished based on novelty or inventive step.
Patent Trends and Litigation
The patent’s novelty stems from specific molecular features or synthesis techniques. Patent litigation or opposition proceedings, if any, may challenge the validity based on:
- Anticipation: Prior art that discloses similar structures or processes.
- Obviousness: Combining prior art making the claimed invention predictable.
- Lack of inventiveness: Demonstrating the claimed compound or method was obvious.
To date, there is no public record of litigation directly related to this patent, but potential enforcement actions remain possible within the scope of the claims.
Licensing and Commercialization Landscape
The patent owner holds licensing agreements with pharmaceutical manufacturers, indicating active development and commercialization plans. The patent’s expiration date is projected around 2032-2033, depending on maintenance fee payments and possible patent term adjustments.
Summary: Patent Strengths and Risks
Strengths
- Broad chemical and use coverage: Protects the compound, its salts, polymorphs, and uses.
- Method claims: Cover synthesis routes, complicating generics manufacturing.
- International coverage: Family extent provides global rights.
Risks
- Potential for invalidation: Based on prior art or obviousness challenges.
- Narrow claims in specific areas: Allowing competitors to design around the compound or synthesis.
- Limited duration: Patent protection ends in 10-15 years, depending on jurisdiction.
Key Takeaways
- US Patent 9,074,254 claims a novel chemical compound with associated therapeutic uses, synthesis methods, and formulations.
- The patent’s claims cover compositions, methods of manufacture, and use, providing a comprehensive shield.
- The patent landscape involves family filings and related patents aimed at protecting similar compounds or methods.
- Strategic risks include potential challenges based on prior art or obviousness, which could narrow enforceability.
- The patent remains valuable for a roughly 10-year horizon, supporting commercial exclusivity and licensing prospects.
Frequently Asked Questions
1. What is the primary novelty in US Patent 9,074,254?
It lies in the specific chemical structure of the compound and its particular synthesis method, distinguishing it from prior art.
2. How broad are the patent claims?
The claims include the chemical compound, related salts and polymorphs, pharmaceutical compositions, synthesis methods, and therapeutic uses, offering extensive coverage.
3. Can competitors develop similar drugs without infringement?
Yes, by designing around the specific molecular features or alternative synthesis routes, but careful legal analysis remains necessary.
4. How long will this patent provide exclusivity?
Expected expiration around 2032–2033, contingent on jurisdiction and maintenance.
5. Are there ongoing litigations related to this patent?
No publicly identified litigations as of now; however, enforcement actions are possible if competitors infringe on the claims.
References
[1] U.S. Patent and Trademark Office. (2015). Patent No. 9,074,254.
[2] European Patent Office. (Family application publications related to US 9,074,254).
[3] WIPO. (Patent family data and international filings).
